Skip to Content

WATSON 416 (Estropipate 3 mg)

Pill with imprint WATSON 416 is Blue, Round and has been identified as Estropipate 3 mg. It is supplied by Watson Pharmaceuticals.

Estropipate is used in the treatment of atrophic vaginitis; hypoestrogenism; oophorectomy; osteoporosis; postmenopausal symptoms and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 3 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 416

Estropipate 3 mg WATSON 416  Front
Estropipate 3 mg WATSON 416  Back
Estropipate 3 mg WATSON 416
Estropipate 3 mg WATSON 416
Estropipate 3 mg WATSON 416

Estropipate

Imprint
WATSON 416
Strength
3 mg
Color
Blue
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Estrogens
Pregnancy Category
X - Not for use in pregnancy
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)
00591-0416
Inactive Ingredients
magnesium stearate, piperazine, corn starch, magnesium silicate, FD&C Blue No. 2

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.